BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
29 août 2024 07h00 HE
|
BioStem Technologies, Inc.
BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
21 août 2024 07h00 HE
|
Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje®
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
12 août 2024 16h14 HE
|
Biostem Technologies
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
05 août 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
10 juil. 2024 07h15 HE
|
Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
26 juin 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
BioStem Technologies to Sponsor MRO Better Half Dash
29 mai 2024 11h00 HE
|
Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
14 mai 2024 16h01 HE
|
Biostem Technologies
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
06 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent